NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
Posted: September 11, 2018.
Category - Medicines Update
The Medicines Update Extra Bulletin on Parkinson’s Disease (PD) in Acute Care has been updated. This consists of a main bulletin and
Posted: September 10, 2018.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: September 07, 2018.
Category - Medicines Update
The NHSGGC Central Prescribing Team maintains several prescribing decision support tools for primary care such as;
Posted: September 05, 2018.
Category - Medicines Update
Key messages The side effect profile of clozapine means it is subject to mandatory processes and monitoring which are intended to ensure patient safety Concurrent use of medications known to cause neutr...
Posted: September 05, 2018.
Category - Medicines Update Extra
MUE 09: Parkinson's Disease in Acute Care** This bulletin supersedes MUE 01 **
Posted: August 20, 2018.
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: August 17, 2018.
Category - Medicines Update
The NHSGGC guideline previously entitled ‘Anti Tumour Necrosis Factor Alpha Medications In Adult Crohn’s Disease’ has been reviewed and updated. This is now available on the Clinical Guideline Repository on Staffnet
Posted: August 17, 2018.
Category - Medicines Update
Name change from enoxaparin Becat® to Arovi® and availability of 120mg and 150mg pre-filled syringes Key points: Enoxaparin Becat® is changing its name to Arovi®....
Posted: August 17, 2018.
Category - Medicines Update
Dipyridamole MR 200mg is currently subject to supply disruptions, with no definitive date as to when or if the situation will be resolved. Persantin Retard® (dipyridamole 200mg MR) has been discontinued by the manufacture...
Posted: August 17, 2018.
Category - Medicines Update
The following information is for all clinicians who initiate prescriptions for ONS (oral nutritional supplements) for patients with dysphagia. In the interests of patient safety, care must be taken with this patient group to avoid aspir...